Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies
Hodgkin lymphoma (HL) is traditionally considered one of the hematological malignancies with the highest rate of cure, ranging from 70 to 90% depending on the disease and patient features [...]
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/5/1928 |
| _version_ | 1797615041754693632 |
|---|---|
| author | Annalisa Paviglianiti Nicolò Rampi |
| author_facet | Annalisa Paviglianiti Nicolò Rampi |
| author_sort | Annalisa Paviglianiti |
| collection | DOAJ |
| description | Hodgkin lymphoma (HL) is traditionally considered one of the hematological malignancies with the highest rate of cure, ranging from 70 to 90% depending on the disease and patient features [...] |
| first_indexed | 2024-03-11T07:20:50Z |
| format | Article |
| id | doaj.art-b5c9300f0f054b3c9843f7240ccf3a2f |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T07:20:50Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-b5c9300f0f054b3c9843f7240ccf3a2f2023-11-17T08:00:15ZengMDPI AGJournal of Clinical Medicine2077-03832023-03-01125192810.3390/jcm12051928Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel TherapiesAnnalisa Paviglianiti0Nicolò Rampi1Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, 08908 Barcelona, SpainClinical Hematology Department, Institut Català d’Oncologia-Hospitalet, 08908 Barcelona, SpainHodgkin lymphoma (HL) is traditionally considered one of the hematological malignancies with the highest rate of cure, ranging from 70 to 90% depending on the disease and patient features [...]https://www.mdpi.com/2077-0383/12/5/1928n/a |
| spellingShingle | Annalisa Paviglianiti Nicolò Rampi Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies Journal of Clinical Medicine n/a |
| title | Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies |
| title_full | Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies |
| title_fullStr | Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies |
| title_full_unstemmed | Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies |
| title_short | Advances and Clinical Outcomes in Hodgkin Lymphoma in the Era of Novel Therapies |
| title_sort | advances and clinical outcomes in hodgkin lymphoma in the era of novel therapies |
| topic | n/a |
| url | https://www.mdpi.com/2077-0383/12/5/1928 |
| work_keys_str_mv | AT annalisapaviglianiti advancesandclinicaloutcomesinhodgkinlymphomaintheeraofnoveltherapies AT nicolorampi advancesandclinicaloutcomesinhodgkinlymphomaintheeraofnoveltherapies |